As new technology capable of detecting dozens of early-stage cancer types with a single blood test hits the market, support ...
The assay detects aggressive prostate tumors in men on active surveillance for low-risk cancer, potentially helping them ...
Canadian research suggests recommendations against screening for prostate cancer has led to a rise in the rates of stage 4 cases and less progress in mortality, even as other experts disagree and cite ...
Atlanta Falcons Legends join Emory Healthcare to raise awareness for prostate and lung cancer screening. Early detection can ...
The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...
Investigators analyzed exfoliated cells in urine specimens to identify 50 candidate RNAs for prostate cancer detection.
Prostate cancer risk factors include some that can’t be changed, such as having a family history of the disease and a genetic predisposition for developing the cancer ...
Diagnosed with prostate cancer at just 42, CEO Tamas Szabo feared he wouldn't see his children grow up. Now he's fighting to ...
The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...
The treatment is suitable for men whose cancer has not spread outside of the prostate gland or has spread to the area just ...
A groundbreaking trial for a prostate cancer treatment with fewer side effects has launched in the UK.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results